Evolus (EOLS) Insider Trading & Ownership $12.69 +0.06 (+0.48%) (As of 10:05 AM ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Evolus (NASDAQ:EOLS) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage6.10%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)7Amount OfInsider Selling(Last 12 Months)$4.18 M Get EOLS Insider Trade Alerts Want to know when executives and insiders are buying or selling Evolus stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address EOLS Insider Buying and Selling by Quarter Ad Priority GoldJD Vance Predicts: Wall Street vs. Trump & Your MoneyTrump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.Get your free guide NOW before it's too late. Evolus Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/6/2024Sandra BeaverCFOSell3,276$14.98$49,074.48 8/30/2024Tomoko Yamagishi-DresslerCMOSell5,631$15.85$89,251.35 6/5/2024David MoatazediInsiderSell155,278$12.92$2,006,191.76 6/3/2024Vikram MalikDirectorSell7,500$12.96$97,200.00 5/13/2024David N GillDirectorSell3,643$12.72$46,338.96 5/10/2024David MoatazediInsiderSell16,051$12.72$204,168.72 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 5/10/2024Sandra BeaverCFOSell2,423$12.72$30,820.56 3/27/2024David MoatazediInsiderSell6,236$13.86$86,430.96 3/19/2024Rui AvelarInsiderSell27,603$13.92$384,233.76 3/19/2024Sandra BeaverCFOSell5,672$13.92$78,954.24 2/22/2024David MoatazediInsiderSell7,706$13.08$100,794.48 2/22/2024Sandra BeaverCFOSell1,821$13.08$23,818.68 1/30/2024Karah Herdman ParschauerDirectorSell11,931$13.14$156,773.34 12/8/2023David MoatazediInsiderSell31,300$9.73$304,549.00 12/6/2023David MoatazediInsiderSell51,348$10.09$518,101.32 (Data available from 1/1/2013 forward) EOLS Insider Trading Activity - Frequently Asked Questions Who is on Evolus's Insider Roster? The list of insiders at Evolus includes Alphaeon 1 Llc, Crystal Muilenburg, David Moatazedi, David N Gill, Karah Herdman Parschauer, Lauren P Silvernail, Medytox Inc., Robert Hayman, Rui Avelar, Sandra Beaver, Tomoko Yamagishi-Dressler, and Vikram Malik. Learn more on insiders at EOLS. What percentage of Evolus stock is owned by insiders? 6.10% of Evolus stock is owned by insiders. Learn more on EOLS's insider holdings. Which Evolus insiders have been buying company stock? The following insider purchased EOLS shares in the last 24 months: Vikram Malik ($1,296,505.47). How much insider buying is happening at Evolus? Insiders have purchased a total of 174,967 EOLS shares in the last 24 months for a total of $1,296,505.47 bought. Which Evolus insiders have been selling company stock? The following insiders have sold EOLS shares in the last 24 months: Alphaeon 1 Llc ($15,540,000.00), David Moatazedi ($3,815,855.11), David N Gill ($46,338.96), Karah Herdman Parschauer ($156,773.34), Medytox Inc. ($31,273,816.00), Rui Avelar ($406,940.73), Sandra Beaver ($213,494.56), Tomoko Yamagishi-Dressler ($89,251.35), and Vikram Malik ($97,200.00). How much insider selling is happening at Evolus? Insiders have sold a total of 6,141,303 Evolus shares in the last 24 months for a total of $51,639,670.05 sold. Evolus Key ExecutivesMr. David Moatazedi (Age 46)President, CEO & Director Compensation: $1.75M1 recent tradesMs. Sandra Beaver (Age 46)Chief Financial Officer Compensation: $740.15k1 recent tradesDr. Rui Avelar C.CFP (Age 62)Dip.SportMed, M.D., Chief Medical Officer and Head of Research & Development Compensation: $823.19kMr. Nareg SagherianHead of Global Investor Relations & Corporate CommunicationsMr. Jeffrey J. PlumerGeneral CounselMr. Kurt KnabVice President of SalesMs. Tomoko Yamagishi-DresslerChief Marketing Officer1 recent tradesMs. Jessica NovakSenior Vice President of Human Resources More Insider Trading Tools from MarketBeat Related Companies MLTX Insider Ownership VRNA Insider Ownership AGIO Insider Ownership MRUS Insider Ownership EWTX Insider Ownership DYN Insider Ownership BHC Insider Ownership XENE Insider Ownership VERA Insider Ownership VCEL Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NASDAQ:EOLS) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evolus, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Evolus With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free EOLS Stock Alerts